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Squamous cell carcinoma (SCCs) of the skin and head
and neck arise through the accumulation of genetic and
epigenetic alterations that contribute to different stages
of tumor progression and the metastatic potential of
these tumors. Advanced SCCs are refractory to current
therapies and exhibit high risk for relapse, and despite
significant advances in prevention and in understanding
the biology of SCCs, there are currently no effective
treatments for patients with metastatic SCCs. Under-
standing the role of the molecular alterations found in
SCCs may facilitate the design of novel therapies to
treat these patients. The most frequently mutated gene
in SCC of the skin and head and neck is the p53 gene,
which is found mutated in up to 50-70% of the SCCs
analyzed. The majority of the p53 mutations found in
SCCs are missense mutations that result in the expres-
sion of altered forms of p53, some of which may pro-
mote tumorigenesis, indicating that p53 is not only a
major tumor suppressor gene, but it may also be a pri-
mary oncogene in SCC. Genetically engineered mouse
models are powerful tools to determine the role of
genetic alterations found in human cancers. We gener-
ated a mouse model for sporadic head and neck cancer
based on the focal activation of endogenous K-ras and
p53 mutations in the oral epithelium. Using this model
we demonstrated that the p53 gain-of-function mutation
p53R172H, but not deletion of p53, contributes to oral
tumor initiation, accelerates tumor growth and pro-
motes malignant progression. Molecular analysis of
tumors and cell lines derived from them determined
that mutant p53 promotes the expression of mitotic
genes and induces accelerated entry in mitosis, a
mechanism that depends on oncogenic K-ras. These
findings provide in vivo evidence for the oncogenic
potential of mutant p53R172H during SCC development
and support clinical observations indicating that certain
p53 mutations are associated with poor prognosis in
SCC of the head and neck. I will discuss the potential
implications of these findings in tumor progression,
resistance to therapy and genomic instability associated
with p53 mutations. As the oncogenic function of
mutant p53 in this mouse model was dependent on
K-ras mutations, we speculate that p53 mutants are acti-
vated in response to oncogenes. To address this ques-
tion, I will further discuss the consequences of
activating p53 gain- and loss-of-function mutations in
the absence of additional genetic alterations in mouse
models in which only p53 mutations are induced in
stratified epithelia of the skin and the oral mucosa. In
addition, novel mouse models generated in our labora-
tory are shedding new light into the function of genes
that cooperate with p53 mutations in the early stages of
SCC formation and during malignant progression and
metastasis.
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